MVM
Medicxi Ventures Management Portfolio holdings
AUM
$427M
This Quarter Return
+65.48%
1 Year Return
+42.94%
3 Year Return
+262.94%
5 Year Return
+109.92%
10 Year Return
–
AUM
$529M
AUM Growth
+$529M
(+58%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.25B
| $319M | 60.35% | 19,963,157 | – | – |
|
2
Phathom Pharmaceuticals
PHAT
$864M
| $135M | 25.52% | 7,464,572 | – | – |
|
3
NewAmsterdam Pharma
NAMS
$2.71B
| $47.6M | 9.01% | 2,869,565 | – | – |
|
4
Aura Biosciences
AURA
$389M
| $27.1M | 5.12% | 3,039,892 | – | – |
|